Literature DB >> 17475827

Cutting edge: cross-presented intracranial antigen primes CD8+ T cells.

Lisa Walter1, Matthew L Albert.   

Abstract

The CNS is considered immune privileged due to the blood-brain barrier and the absence of conventional lymphatics. Nonetheless, T cell immune responses specific for CNS Ag have been documented. Where these events are initiated and what cellular mechanisms are involved remain unknown. In this study, we established an experimental mouse model to evaluate the requirements for priming CD8+ T cells following the cross-presentation of intracranial Ag. Surprisingly, we find that even with a damaged blood-brain barrier, Ag presentation occurs in regional lymph nodes and not within the CNS itself. Only once the responding cells have expanded can they traffic to the site of CNS injury. Cross-presentation of intracranial Ag is efficient and the subsequent priming of CD8+ T cells is dependent on CD4+ T cell help and CD40 signaling in host APCs. Our findings have important implications for the initiation of T cell immune responses toward CNS Ags.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475827     DOI: 10.4049/jimmunol.178.10.6038

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis.

Authors:  Timothy W Phares; Stephen A Stohlman; Mihyun Hwang; Booki Min; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

Review 2.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

Authors:  Gavin P Dunn; Ian F Dunn; William T Curry
Journal:  Cancer Immun       Date:  2007-08-13

3.  Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapy.

Authors:  Houria Hendel-Chavez; Marie-Ghislaine de Goër de Herve; Claire Giannesini; Anne-Aurélie Mazet; Caroline Papeix; Céline Louapre; Audrey Chardain; Nassima Boutarfa; Marie Théaudin; David Adams; Jacques Gasnault; Bruno Stankoff; Yassine Taoufik
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

Review 4.  Inflammation on the mind: visualizing immunity in the central nervous system.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

5.  The dendritic and T cell responses to herpes simplex virus-1 are modulated by dietary vitamin E.

Authors:  Patricia A Sheridan; Melinda A Beck
Journal:  Free Radic Biol Med       Date:  2009-03-19       Impact factor: 7.376

Review 6.  Encephalitogenic and Regulatory CD8 T Cells in Multiple Sclerosis and Its Animal Models.

Authors:  Taryn E Mockus; Ashley Munie; Jeffrey R Atkinson; Benjamin M Segal
Journal:  J Immunol       Date:  2021-01-01       Impact factor: 5.422

7.  Immune privilege of the CNS is not the consequence of limited antigen sampling.

Authors:  Melissa G Harris; Paul Hulseberg; Changying Ling; Jozsef Karman; Benjamin D Clarkson; Jeffrey S Harding; Mengxue Zhang; Adam Sandor; Kelsey Christensen; Andras Nagy; Matyas Sandor; Zsuzsanna Fabry
Journal:  Sci Rep       Date:  2014-03-21       Impact factor: 4.379

8.  Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8 + T cell responses.

Authors:  Courtney S Malo; Matthew A Huggins; Emma N Goddery; Heather M A Tolcher; Danielle N Renner; Fang Jin; Michael J Hansen; Larry R Pease; Kevin D Pavelko; Aaron J Johnson
Journal:  Nat Commun       Date:  2018-02-12       Impact factor: 14.919

9.  Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook.

Authors:  Patrick C Gedeon; Cosette D Champion; Kristen E Rhodin; Karolina Woroniecka; Hanna R Kemeny; Alexa N Bramall; Joshua D Bernstock; Bryan D Choi; John H Sampson
Journal:  Expert Rev Clin Pharmacol       Date:  2020-09-11       Impact factor: 5.045

Review 10.  Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites.

Authors:  Powell Perng; Michael Lim
Journal:  Front Oncol       Date:  2015-07-06       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.